文章摘要
引用本文:朱丹玲 周云仙 徐红文.炎症性肠病简明健康量表的汉化及信度效度检验[J].中国护理管理,2018,18(12):1630-1634 本文二维码信息
二维码(扫一下试试看!)
炎症性肠病简明健康量表的汉化及信度效度检验
Reliability and validity of the Chinese version of the Short Health Scale for Inflammatory Bowel Diseases
  
DOI:10.3969/j.issn.1672-1756.2018.12.010
中文关键词:  炎症性肠病  简明健康量表  信度  效度
English Keywords:Inflammatory Bowel Disease  Short Health Scale  reliability  validity
基金项目:
作者单位
朱丹玲 周云仙 徐红文 浙江中医药大学护理学院310053 杭州市 
摘要点击次数: 1058
全文下载次数: 0
中文摘要:
      目的:汉化瑞典Henrik博士制定的炎症性肠病简明健康量表,进行信度、效度测试,评价其在我国应用的可行性。方法:汉化并修订炎症性肠病简明健康量表,形成中文版初稿,并在154名炎症性肠病患者中进行信度、效度和已知族群效度的测评。结果:中文版炎症性肠病简明健康量表的Cronbach’s α系数在克罗恩病和溃疡性结肠炎患者中分别为0.887和0.914,各条目的重测信度均大于0.7。量表各条目与22个条目的炎症性肠病生活质量问卷、中文版炎症性肠病患者所关注分级表的相近维度相关性较好,与疾病活动指数中高度相关。将克罗恩病和溃疡性结肠炎患者分别分为活动组与缓解组,除克罗恩病患者自觉健康状况条目外,其余条目两组间比较差异均有统计学意义(P<0.05)。结论:中文版炎症性肠病简明健康量表具有较好的信度、效度和区分能力,可初步用于临床炎症性肠病患者的健康相关生活质量评价。
English Summary:
      Objective: To translate the Short Health Scale (SHS) for Inflammatory Bowel Diseases (IBD) formulated by Dr. Henrik from Swedish into Chinese, test the reliability and validity of the Chinese version, and evaluate its feasibility in China. Methods: The Chinese version of SHS for IBD was developed and the reliability, validity and known-groups validity of the scale were evaluated among 154 patients with IBD. Results: The Cronbach 'alpha coefficient of the Chinese version was 0.887 and 0.914 in the patients with Crohn's Disease (CD) and Ulcerative Colitis (UC), respectively, the retest reliability of each item was more than 0.7. Each item of the scale showed good correlation with the similar dimension of the 22-item IBD quality-of-life questionnaire (IBDQOL-22) and the Chinese version of the Rating Form of IBD Patient Concerns (RFIPC), and was moderately correlated with the disease activity index. The patients with CD and UC were divided into the active group and the remission group respectively. Except for the item of conditions consciously felt by patients with CD, comparison of the rest items between the two groups showed difference with statistical significance (P<0.05). Conclusion: The Chinese version of the SHS for patients with IBD has good reliability, validity and known-groups validity, and can be used for the evaluation of the health related quality of life of patients with IBD.
查看全文  查看/发表评论  下载PDF阅读器